Skip to main content
. 2015 Nov 16;10:41. doi: 10.1186/s13027-015-0034-9

Table 2.

Knowledge of genotypes included in the vaccine (N = 164)

Bivalent vaccine (Cervarix ® contains VLPs of HPV 16 and 18)
 • Knowledge of HPV 16 1 (0.61)
 • Knowledge of HPV 16 and 18 62 (37.8)
 • No knowledge of any of them 101 (61.6)
Quadrivalent vaccine (Gardasil® contains VLPs OF HPV 16, 18, 11 y 6)
 • Knowledge of all of them 54 (32.9)
 • No knowledge of any them 99(60.4)
 • Knowledge of HPV 16 and 18 5 (3)
 • Knowledge of HPV 11 and 18 1 (0.6)
 • Knowledge of HPV 6 and 18 1 (0.6)
 • Knowledge of HPV 6, 11 and 18 2 (1.22)
 • Knowledge of HPV 11, 16 and 18 2 (1.22)
Global knowledge
 • Knowledge of every genotypes of both vaccine 46 (28)
 • Knowledge of the genotypes of bivalent vaccine. 16 (9.7)
 • Knowledge of the genotypes of quadrivalent vaccine. 8 (4.8)
 • No knowledge of any of the serotypes 94 (57.3)
Value in n (%) or Mean ± ST (Range))